Clinical trial
Relative Potency of Inhaled Corticosteroids
NCT00292838 · St. Joseph's Healthcare Hamilton, Other · Completed
Key facts
| NCT number | NCT00292838 |
|---|---|
| Title | Relative Potency of Inhaled Corticosteroids |
| Official title | Relative Potency of Inhaled Corticosteroids: Validation of a Clinical Model |
| Lead sponsor | St. Joseph's Healthcare Hamilton, Other |
| Collaborators | GlaxoSmithKline Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Asthma, Chronic Obstructive Pulmonary Disease (COPD) |
| Intervention type | Drug |
| Interventions | fluticasone 25, 50, 100, 200 mcg |
| Enrollment | 40 |
| Start date | Jan 1, 2001 |
| Primary completion | Feb 1, 2007 |
| Completion | Feb 1, 2007 |
| First posted | Feb 16, 2006 |
| Last update posted | Jul 20, 2011 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: